Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
前日終値
$0.428
−$0.0152 · -3.43%
時間外
$0.428
$0.00 · 0.00%
10月9日 16:01 ET
日中の時刻はETです。市場データは遅延する場合があります。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日中レンジ
現在 $0.428
52週レンジ
現在 $0.428
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
82
大幅な割安
センチメント
59
まちまち
リスク
74
高リスク
モメンタム
48
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
日中レンジ
現在 $0.428
52週レンジ
現在 $0.428
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 27.62億 USD | 107.01億 USD | 103.34億 USD | 99.55億 USD | 97.85億 USD |
| 売上原価 | 14.73億 USD | 84.82億 USD | 82.09億 USD | 81.29億 USD | 82.72億 USD |
| 粗利益 | 12.89億 USD | 22.19億 USD | 21.25億 USD | 18.26億 USD | 15.13億 USD |
| 研究開発 | — | — | — | — | 1210万 USD |
| 販売・一般管理 | 10.68億 USD | 19.1億 USD | 18.14億 USD | 15.55億 USD | 10.77億 USD |
| 営業費用 | 10.68億 USD | 24.27億 USD | 20.21億 USD | 16.83億 USD | 11.45億 USD |
| 支払利息 | 1.07億 USD | 1.44億 USD | 1.58億 USD | 1.29億 USD | 4809万 USD |
| 減価償却費と償却費 | 2.15億 USD | 2.65億 USD | 2.87億 USD | 2.29億 USD | 9062.1万 USD |
| 営業利益 | 2.22億 USD | −2.08億 USD | 1.05億 USD | 1.43億 USD | 3.68億 USD |
| 純利益 | −11.01億 USD | −3.63億 USD | −4130.1万 USD | 2238.9万 USD | 2.22億 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2010年4月1日 | 3:2 | — | — |
株式分割 | 1994年6月9日 | 3:2 | — | — |
株式分割 | 1993年3月23日 | 3:2 | — | — |
株式分割 | 1991年7月17日 | 3:2 | — | — |
株式分割 | 1988年6月1日 | 3:2 | — | — |
株式分割 | 1985年9月3日 | 3:2 | — | — |
発効済み 2010年4月1日
3:2
発効済み 1994年6月9日
3:2
発効済み 1993年3月23日
3:2
発効済み 1991年7月17日
3:2
発効済み 1988年6月1日
3:2
発効済み 1985年9月3日
3:2
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI264.5万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard U.S. Value Factor ETFVFVA145.96万0.17%9.57億 USD0.13%$153.78-0.36%
Vanguard Extended Market ETFVXF100.83万0.00%954億 USD0.05%$235+0.80%
iShares Russell 2000 ETFIWM89.54万0.00%782.66億 USD0.19%$278.94+0.49%
Schwab Fundamental U.S. Small Company Index ETFFNDA55.88万0.01%87.6億 USD0.25%$35.62+0.17%
Vanguard Russell 2000 ETFVTWO49.98万0.00%180億 USD0.06%$112.66+0.50%
iShares Russell 2000 Value ETFIWN29.31万—138.48億 USD0.24%$210.87-0.04%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV23.46万0.00%268.09億 USD0.33%$37.95-0.39%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard U.S. Value Factor ETFVFVA
Vanguard Extended Market ETFVXF
iShares Russell 2000 ETFIWM
Schwab Fundamental U.S. Small Company Index ETFFNDA
Vanguard Russell 2000 ETFVTWO
iShares Russell 2000 Value ETFIWN
U.S. Small Cap Value Portfolio ETF Class SharesDFSVAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。